Is This Medication Safe for My Child? How to Discuss Safety of Commonly Used Medications With Parents.

Skoner, David P; Golant, Alexandra K; Norton, Allison E; Stukus, David R

Skoner, David P; Golant, Alexandra K; Norton, Allison E; Stukus, David R.

Afiliación

Skoner DP; Section of Allergy and Immunology, West Virginia University Children's Hospital, Morgantown, WVa.
Golant AK; Department of Dermatology and Laboratory of Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, New York, NY.
Norton AE; Division of Allergy, Immunology and Pulmonology, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tenn.
Stukus DR; Division of Allergy and Immunology, Nationwide Children's Hospital, Department of Pediatrics, College of Medicine, The Ohio State University, Columbus, Ohio. Electronic address: david.stukus@nationwidechildrens.org.

J Allergy Clin Immunol Pract ; 10(12): 3064-3072, 2022 Dec.

Article en En | MEDLINE | ID: mdl-35963511

Asunto(s)

Asma; Dermatitis Atópica; Adulto; Estados Unidos; Niño; Humanos; Asma/tratamiento farmacológico; Dermatitis Atópica/tratamiento farmacológico; United States Food and Drug Administration

Palabras clave

Allergic rhinitis; Asthma; Atopic Dermatitis; Calcineurin inhibitors; Children; Corticosteroids; Long-acting beta agonists; Montelukast; Safety

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Asma / Dermatitis Atópica Límite: Adult / Child / Humans País/Región como asunto: America do norte Idioma: En Revista: J Allergy Clin Immunol Pract Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google